These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30448598)

  • 121. Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism.
    Saeedi R; Mojebi-Mogharar A; Sandhu SK; Dubland JA; Ford JA; Yousefi M; Pudek M; Holmes DT; Erb SR; Peter Kwan W; Kendler DL; Yoshida EM
    Ann Hepatol; 2017; 16(2):207-214. PubMed ID: 28233741
    [TBL] [Abstract][Full Text] [Related]  

  • 122. A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study.
    Bahardoust M; Mokhtare M; Barati M; Bagheri-Hosseinabadi Z; Karimi Behnagh A; Keyvani H; Agah S
    J Infect Chemother; 2020 Dec; 26(12):1265-1271. PubMed ID: 32762882
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Efficacy and safety of long-term postpartum antiviral therapy in hepatitis B virus-infected mothers receiving prophylactic tenofovir disoproxil fumarate treatment.
    Feng Y; Yao N; Shi L; Zhu Y; Liu J; He Y; Zhao Y; Chen T
    Eur J Gastroenterol Hepatol; 2023 Feb; 35(2):212-218. PubMed ID: 36574312
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-Analysis.
    Yang Q; Zhong Z; Yang Y; Ma Y; Flomo KT
    Gastroenterol Hepatol; 2020 Dec; 43(10):640-648. PubMed ID: 32948358
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load.
    Li B; Liu Z; Liu X; Liu D; Duan M; Gu Y; Liu Q; Ma Q; Wei Y; Wang Y
    Hepatol Int; 2021 Oct; 15(5):1103-1108. PubMed ID: 34312798
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).
    Fung S; Gordon SC; Krastev Z; Horban A; Petersen J; Sperl J; Gane E; Jacobson IM; Yee LJ; Dinh P; Martins EB; Flaherty JF; Kitrinos KM; Dusheiko G; Trinh H; Flisiak R; Rustgi VK; Buti M; Marcellin P
    Liver Int; 2015 Feb; 35(2):422-8. PubMed ID: 25277773
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir.
    Da Wang F; Zhou J; Li LQ; Li YJ; Wang ML; Tao YC; Zhang DM; Wang YH; Chen EQ
    Ann Hepatol; 2023; 28(5):101119. PubMed ID: 37271480
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
    Hsu YC; Yeh ML; Wong GL; Chen CH; Peng CY; Buti M; Enomoto M; Xie Q; Trinh H; Preda C; Liu L; Cheung KS; Yeo YH; Hoang J; Huang CF; Riveiro-Barciela M; Kozuka R; Istratescu D; Tsai PC; Accarino EV; Lee DH; Wu JL; Huang JF; Dai CY; Cheung R; Chuang WL; Yuen MF; Wong VW; Yu ML; Nguyen MH
    J Infect Dis; 2021 Dec; 224(11):1890-1899. PubMed ID: 33999179
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Tenofovir alafenamide for the treatment of chronic hepatitis B virus infection.
    Abdul Basit S; Dawood A; Ryan J; Gish R
    Expert Rev Clin Pharmacol; 2017 Jul; 10(7):707-716. PubMed ID: 28460547
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naïve Patients with Chronic Hepatitis B in Korea.
    Kwon JH; Song MJ; Jang JW; Bae SH; Choi JY; Yoon SK; Kim HY; Kim CW; Song DS; Chang UI; Yang JM; You CR; Choi SW; Lee HL; Lee SW; Han NI; Nam SW; Kim SG; Kim YS; Kim SH; Lee BS; Lee TH; Cho EY
    Dig Dis Sci; 2019 Jul; 64(7):2039-2048. PubMed ID: 30725293
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Long-term treatment with tenofovir in Asian-American chronic hepatitis B patients is associated with abnormal renal phosphate handling.
    Tien C; Xu JJ; Chan LS; Chang M; Lim C; Lee S; Huh B; Shinada S; Bae HS; Fong TL
    Dig Dis Sci; 2015 Feb; 60(2):566-72. PubMed ID: 25239496
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Efficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settings.
    Pan CQ; Trinh H; Yao A; Bae H; Lou L; Chan S;
    PLoS One; 2014; 9(3):e89789. PubMed ID: 24594870
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study.
    Ogawa E; Nakamuta M; Koyanagi T; Ooho A; Furusyo N; Kajiwara E; Dohmen K; Kawano A; Satoh T; Takahashi K; Azuma K; Yamashita N; Yamashita N; Sugimoto R; Amagase H; Kuniyoshi M; Ichiki Y; Morita C; Kato M; Shimoda S; Nomura H; Hayashi J;
    Hepatol Int; 2022 Apr; 16(2):282-293. PubMed ID: 35075593
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate.
    Kaneko S; Kurosaki M; Tamaki N; Itakura J; Hayashi T; Kirino S; Osawa L; Watakabe K; Okada M; Wang W; Shimizu T; Higuchi M; Takaura K; Yasui Y; Tsuchiya K; Nakanishi H; Takahashi Y; Watanabe M; Izumi N
    J Gastroenterol Hepatol; 2019 Nov; 34(11):2004-2010. PubMed ID: 31017689
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial.
    Hsu YC; Chen CY; Chang IW; Chang CY; Wu CY; Lee TY; Wu MS; Bair MJ; Chen JJ; Chen CC; Tseng CH; Tai CM; Huang YT; Ku WH; Mo LR; Lin JT
    Lancet Infect Dis; 2021 Jun; 21(6):823-833. PubMed ID: 33524314
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection.
    Seto WK; Asahina Y; Brown TT; Peng CY; Stanciu C; Abdurakhmanov D; Tabak F; Nguyen TT; Chuang WL; Inokuma T; Ikeda F; Santantonio TA; Habersetzer F; Ramji A; Lau AH; Suri V; Flaherty JF; Wang H; Gaggar A; Subramanian GM; Mukewar S; Brunetto MR; Fung S; Chan HL
    Clin Gastroenterol Hepatol; 2018 Jun; ():. PubMed ID: 29933096
    [TBL] [Abstract][Full Text] [Related]  

  • 137. A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
    Kim DY; Kim YR; Suh C; Yoon DH; Yang DH; Park Y; Eom HS; Lee JO; Kwak JY; Kang HJ; Hyun SY; Jo JC; Chang MH; Yoo KH; Lim SN; Shin HJ; Kim WS; Kim IH; Kim MK; Kim HJ; Lee WS; Mun YC; Kim JS
    Am J Gastroenterol; 2023 Aug; 118(8):1373-1380. PubMed ID: 36728217
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial.
    Wedemeyer H; Schöneweis K; Bogomolov P; Blank A; Voronkova N; Stepanova T; Sagalova O; Chulanov V; Osipenko M; Morozov V; Geyvandova N; Sleptsova S; Bakulin IG; Khaertynova I; Rusanova M; Pathil A; Merle U; Bremer B; Allweiss L; Lempp FA; Port K; Haag M; Schwab M; Zur Wiesch JS; Cornberg M; Haefeli WE; Dandri M; Alexandrov A; Urban S
    Lancet Infect Dis; 2023 Jan; 23(1):117-129. PubMed ID: 36113537
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Tenofovir alafenamide (TAF) treatment of HBV, what are the unanswered questions?
    Viganò M; Loglio A; Grossi G; Lampertico P
    Expert Rev Anti Infect Ther; 2018 Feb; 16(2):153-161. PubMed ID: 29338458
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Role of plasmatic and urinary concentration of tenofovir disoproxil fumarate in a cohort of patients affected by chronic hepatitis B.
    Boglione L; De Benedetto I; Dodaro V; Chiecchio M; De Nicolò A; Di Perri G; D'Avolio A
    Arch Virol; 2022 Aug; 167(8):1669-1674. PubMed ID: 35598207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.